Unblinded: A Clinical Trial Podcast A People-Focused Approach to a Risk-Based Future in Clinical Trials
Jan 29, 2026
Anna Hayes, senior director of clinical data management at Veramed with nearly 20 years in CRO data and project management. Noeleen Turner, head of clinical data management at UCB with pharma leadership across Pfizer and GSK. They discuss platform vs point solutions, people and change management, endpoint-driven design, risk-based data practices, unified platforms, and calls for leaner, greener trials.
AI Snips
Chapters
Transcript
Episode notes
Over‑Communicate During Change
- Over-communicate and take teams on the change journey when introducing new tools.
- Listen to feedback so teams feel heard and understand the benefits of change.
Data Leaders Gain Voice With Endpoint Focus
- Data leaders can gain influence by pushing risk‑based, endpoint‑focused approaches.
- Focusing on critical data collection and quality-by-design raises data management's voice at the trial table.
Real-Time Data Is Still Rare
- Most trials are not close to real-time data, especially for external sources.
- Multiple vendor feeds and monthly deliveries create data currency challenges for decision making.